Acceder

Farmas USA

136K respuestas
Farmas USA
85 suscriptores
Farmas USA
Página
6.751 / 17.026
#54001

Re: Farmas USA

Exel

Voy modo movil y no puedo poner link. Presenta malos datos de su fase2, mal rollo de cara a la fase3 que presenta en 2015. Recorta nuevamente fuerzas de venta con lo que la confianza en el producto es poca

#54002

Re: Farmas USA

Exelixis, Inc. (Nasdaq: EXEL) announced top-line results from the final analysis of COMET-2, a randomized, double-blind, controlled trial of cabozantinib in men with metastatic castration-resistant prostate cancer (mCRPC) who are suffering from moderate to severe pain despite optimized narcotic medication, and whose disease has progressed following treatment with docetaxel as well as abiraterone and/or enzalutamide. The trial did not meet its primary endpoint of alleviation of bone pain, as determined by comparing the percentage of patients in the two treatment arms who achieved a pain response at Week 6 that was confirmed at Week 12 without increase in narcotic medication. Fifteen percent of patients in the cabozantinib arm reported a pain response, compared to 17 percent of patients in the control arm receiving mitoxantrone/ prednisone. The difference in pain response between the arms was not statistically significant. The safety profile of cabozantinib in the trial was consistent with that observed in previous studies in mCRPC.

EXEL

#54003

Re: Farmas USA

100 acciones a 1,39$ ?!?!
Que cosas estos PM...

AMRN

#54007

Re: Farmas USA

EXEL

Pura suerte!. Hizo un movimiento que no me gustó la semana pasada y pensé que debería haber empezado ya el runup, cuando la tuve en verde me salí. El problema es que pienso lo mismo del resto de farmas que tengo en cartera. Veo corrección en el horizonte y las tengo todas en rojo menos NVAX. Mal aspecto tiene el SP.

#54008

Re: Farmas USA

NVAX

Sabes lo que estoy pensando verdad?